Drugs / neutral protamine Hagedorn
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02012465 | Sep 2013 → May 2015 | hyperglycemia, lymphoma, type 2 diabetes mellitus | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | neutral protamine Hagedorn | “neutral protamine Hagedorn (NPH) insulin” NCT02012465 ↗ |
| Known as | NPH | “confirm NPH insulin dosing” NCT02012465 ↗ |
| Modality | Protein / enzyme biologic | “neutral protamine Hagedorn (NPH) insulin” NCT02012465 ↗ |
| Route | Subcutaneous | “all insulin in this study is to be administered subcutaneously” NCT02012465 ↗ |